Seeking Alpha

Amgen (AMGN) agrees to buy 95.6% of privately-held Turkish company Mustafa Nevzat...

Amgen (AMGN) agrees to buy 95.6% of privately-held Turkish company Mustafa Nevzat Pharmaceuticals for an amount that values the firm at $700M. The acquisition will help AMGN expand its operations in the fast-growing Turkish market and surrounding region (also: earnings). AMGN +1.3% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs